Responder analysis for fev1 improvement with dupilumab in patients with persistent asthma and elevated eosinophil levels

Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2014
This article has no abstract
Epistemonikos ID: e16ace7dd541a9a96e344c0b46b611feddc6198c
First added on: Feb 07, 2025